University of Wisconsin School of Medicine: Cell Therapy for Sjogren's Disease Earns FDA Fast Track Designation
February 10, 2026
February 10, 2026
MADISON, Wisconsin, Feb. 10 -- The University of Wisconsin School of Medicine and Public Health issued the following news:
* * *
Cell therapy for Sjogren's disease earns FDA Fast Track designation
A therapy currently being tested in a clinical trial at the University of Wisconsin School of Medicine and Public Health to treat a common symptom of Sjogren's disease recently got a boost from the Food and Drug Administration.
The novel exp . . .
* * *
Cell therapy for Sjogren's disease earns FDA Fast Track designation
A therapy currently being tested in a clinical trial at the University of Wisconsin School of Medicine and Public Health to treat a common symptom of Sjogren's disease recently got a boost from the Food and Drug Administration.
The novel exp . . .